SlideShare a Scribd company logo
1 of 88
Download to read offline
PRACTICAL APPROACH TO
PATIENTS WITH NEPHROTIC
SYNDROME

 Vasant Sumethkul M.D.
 Professor of Medicine
 Ramathibodi Hospital
 Mahidol University
ตวอยางผู วย
ตัวอยางผปวย

หญิงไทยโสดอายุ 40 ป มาโรงพยาบาลดวยอาการบวม
และยุบ เปนและหาย มา 1 เดอน
        ป                   ื
มีประวัติปสสาวะเปนฟอง แตไมมีเลือด
และปริมาณปสสาวะออกดี
ไม ี ป
ไ มโรคประจํําตััว และปฏิเิ สธการทานยาเปนประจํํา
                     ป                ป ป
T 36 BP 140/90 HR 80

Not pale, no jaundice, pitting edema 4+

Heart no gallop rhythm

Lung no crepitation
L           i i

Abdomen no palpable mass, fluid thrill

Positive, no superficial vein dilatation
CBC Hb 13.0 WBC 8500 PMN 70 L30
    platelet 240,000

UA sp gr 1020, protein 4+, RBC 3-5
   WBC 0-1, oval fat body 1-2, no cast
          0 1,              1 2,
   spot UPCR = 4

TP 70 G/L, Albumin 20 G/L,
Chol
Ch l 350 mg/dl, Triglyceride 300 mg/dl
           /dl T i l     id        /dl

BUN 10 mg/dl, Serum Cr 1.2 mg/dl
What should you do next ?

1. Screen for ANA, anti DNA,C3, C4, CH 50
                 ,         , , ,

2. Bed rest and furosemide 40 mg/day
                               g y

3.
3 Start prednisolone 1 mg/kg/day

4. Collect
4 C ll t 24 h
            hour urine protein
                   i      t i
other
                       3% 3% 3% 4%            IgA
                                              IgM
           19%
                                              Membranous
                                       29%    ain
                                              cgn

          10%                                 dn
                                              fsgs
                 6%                           lupus
                      4% 1%     18%
                                              mes gn
                                              minimal change

Figure 3: Renal Histopathology of
patients with nephrotic range proteinuria (N=217)
Percent of Secondary Glomerulonephritis

                                                   post inf
    100%
                                                   lupus
     80%
                                                   henoch-sc
     60%                                           MM
     40%                                           light_c
     20%                                           DN

      0%                                           Cryo
                                                   Anti GBM
           <20     20-40          40-60      >60
                                                   Amyloidos
                           Age group (yrs)

 Figure 2: Secondary glomerulonephritis by age (n=391)
ผล   ANA negative, anti DNA negative
     C3, C4 and CH 50 within normal limit
     HBsAg negative, anti HCV negative,
           g g      ,             g   ,
     Anti HIV (with consent) negative

     CXR no pulmonary infiltration
     Stool examination ; no p
                            parasite found

     ผูปวยยังมีอาการบวม และน้าหนักขึ้น 2 กิโลกรัม ใน 1 week
        ู                      ํ
What should you do next ?

1. Bed rest and furosemide 40 mg/day
                               g y

2. Start prednisolone 1 mg/kg/day

3.
3 Advise renal biopsy

4. Repeat serum creatinine
4 R     t           ti i
Percent of Primary GN

   100%
                                              mini
    80%                                       Membranous

    60%                                       fsgs
                                              mes gn
    40%
                                              IgM
    20%                                       IgA
                                              mpgn
     0%
                                              crescentic gn
          <20    20 40
                 20-40          40 60
                                40-60   >60
                    Age group (yrs)




Figure 1: Primary glomerulonephritis by age (n=568)
The patient deny renal biopsy and
received prednisolone 50 mg/daily for 4
weeks.
How can you characterize the response
to corticosteroid ?

1.
1 Diuresis
2. Decrease body weight
3. Decrease proteinuria
3 D             t i  i
4. Increase serum albumin
5. Decrease serum cholesterol
Clinical findings that strongly against
the diagnosis of MCNS

1.   RBC cast
2.   Hypocomplementemia
3.   Gross hematuria
4.
4    Severe uncontrolled hypertension
5.   Rapidly progressive renal failure
6.
6    Organomegaly
     O           l
The patient received prednisolone 50
mg/daily for 8 weeks.
Spot UPCR decrease to 1.5
 p
Serum albumin = 25 G/L.

What should you do next ?
1.
1 Continue prednisolone 50 mg/daily to
   16 weeks
2.
2 Add cyclophosphamide 100 mg/day
           l h h id            /d
3. Add cyclosporin 150 mg/day
4. Advise renal biopsy
The patient agree for renal biopsy at

8 weeks, the results are shown here.

What is your diagnosis ?
After renal biopsy, the patient receive
prednisolone 30-40 mg/daily and
cyclophosphamide 100 mg/day for
 y p p                    g y
another 8 weeks.

At 16 weeks, proteinuria is 2+
spot UPCR = 0 5
              0.5
Serum albumin increase to 38 G/L

What should you do next ?
1. Increase prednisolone to 40 mg/day and
   continue cyclophosphamide 100 mg/day for
   another 4 weeks

2. Add cyclosporin ; keep trough level
    75-120 ng/dl

3. Continue low dose of Prednisolone and
   cyclophosphamide and add ACEI keep BP <
   130/80

4. Repeat renal biopsy
Response to therapy of MCNS

1. Complete remission:

   Proteinuria trace or negative X 2

   24 hour Proteinuria < 300 mg/day
                i   i          /

2.
2 Partial remission:

   Proteinuria < 1-2 gram/day
                     g      y

   Proteinuria < 50 % of baseline with normal

   serum albumin
Steroid non responsive (resistance) MCNS

1. Proteinuria > 3 5 gram /d after 16 weeks
1 P t i     i    3.5      /day ft        k

2.
2 Patients who do not have criteria for partial

   remission after adequate therapy
                      q          py
If renal biopsy shows FSGS :

What is the different approach ?
If renal biopsy shows
  Membranous
  glomerulonephritis :

What is the different approach ?
SUMMARY

1. The prediction of renal pathology from
   clinical setting is not accurate

2. The long term prognosis of p
          g      p g          patient with
   nephrotic syndrome is generally good

3. Over immunosuppression should be
   avoided
Thank you for your attention
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome
Practical approach to_nephrotic_syndrome

More Related Content

What's hot

Nephrotic syndrome by Dr. swarupchinta
Nephrotic syndrome by Dr. swarupchintaNephrotic syndrome by Dr. swarupchinta
Nephrotic syndrome by Dr. swarupchintaSwarup Chinta
 
Proteinuria Evaluation
Proteinuria EvaluationProteinuria Evaluation
Proteinuria Evaluationtarun kumar
 
Crescentric Glomerulonephritis (RPGN)
Crescentric Glomerulonephritis (RPGN)Crescentric Glomerulonephritis (RPGN)
Crescentric Glomerulonephritis (RPGN)Ali Akram Ali Uthuman
 
Minimal change disease
Minimal change diseaseMinimal change disease
Minimal change diseaseHuzaifa Zahoor
 
Nephrotic syndrome
Nephrotic syndromeNephrotic syndrome
Nephrotic syndromeNEHA BHARTI
 
C:\documents and settings\administrator\桌面\20100607 nephrotic syndrome
C:\documents and settings\administrator\桌面\20100607 nephrotic syndromeC:\documents and settings\administrator\桌面\20100607 nephrotic syndrome
C:\documents and settings\administrator\桌面\20100607 nephrotic syndromeinternalmed
 
Approach to Nephritic Syndrome
Approach to Nephritic SyndromeApproach to Nephritic Syndrome
Approach to Nephritic Syndromekkcsc
 
Nephrotic syndrome IN CHILDREN Lecture for MBBS
Nephrotic syndrome IN CHILDREN  Lecture for MBBSNephrotic syndrome IN CHILDREN  Lecture for MBBS
Nephrotic syndrome IN CHILDREN Lecture for MBBSSajjad Sabir
 
Evaluation of proteinuria in children ppt
Evaluation of proteinuria in children pptEvaluation of proteinuria in children ppt
Evaluation of proteinuria in children pptShane Watson
 
Proteinuira & Glomerular Disease, Dr. Sara Arnold, 11/8/14
Proteinuira & Glomerular Disease, Dr. Sara Arnold, 11/8/14Proteinuira & Glomerular Disease, Dr. Sara Arnold, 11/8/14
Proteinuira & Glomerular Disease, Dr. Sara Arnold, 11/8/14upstatevet
 
Nephrotic syndrome in children. for under graduates
Nephrotic syndrome in children. for under graduatesNephrotic syndrome in children. for under graduates
Nephrotic syndrome in children. for under graduatesSajjad Sabir
 
Nephrotic syndrome final
Nephrotic syndrome finalNephrotic syndrome final
Nephrotic syndrome finalakilav99
 

What's hot (20)

Nephrotic syndrome by Dr. swarupchinta
Nephrotic syndrome by Dr. swarupchintaNephrotic syndrome by Dr. swarupchinta
Nephrotic syndrome by Dr. swarupchinta
 
Nephrotic Syndrome
Nephrotic SyndromeNephrotic Syndrome
Nephrotic Syndrome
 
Proteinuria Evaluation
Proteinuria EvaluationProteinuria Evaluation
Proteinuria Evaluation
 
Nephrotic syndrome
Nephrotic syndromeNephrotic syndrome
Nephrotic syndrome
 
Crescentric Glomerulonephritis (RPGN)
Crescentric Glomerulonephritis (RPGN)Crescentric Glomerulonephritis (RPGN)
Crescentric Glomerulonephritis (RPGN)
 
Minimal change disease
Minimal change diseaseMinimal change disease
Minimal change disease
 
Nephrotic Syndrome
Nephrotic SyndromeNephrotic Syndrome
Nephrotic Syndrome
 
Nephrotic syndrome
Nephrotic syndromeNephrotic syndrome
Nephrotic syndrome
 
Nephrotic Syndrome
Nephrotic SyndromeNephrotic Syndrome
Nephrotic Syndrome
 
C:\documents and settings\administrator\桌面\20100607 nephrotic syndrome
C:\documents and settings\administrator\桌面\20100607 nephrotic syndromeC:\documents and settings\administrator\桌面\20100607 nephrotic syndrome
C:\documents and settings\administrator\桌面\20100607 nephrotic syndrome
 
Approach to Nephritic Syndrome
Approach to Nephritic SyndromeApproach to Nephritic Syndrome
Approach to Nephritic Syndrome
 
Nephrotic syndrome IN CHILDREN Lecture for MBBS
Nephrotic syndrome IN CHILDREN  Lecture for MBBSNephrotic syndrome IN CHILDREN  Lecture for MBBS
Nephrotic syndrome IN CHILDREN Lecture for MBBS
 
Evaluation of proteinuria in children ppt
Evaluation of proteinuria in children pptEvaluation of proteinuria in children ppt
Evaluation of proteinuria in children ppt
 
Nephrotic syndrome
Nephrotic syndromeNephrotic syndrome
Nephrotic syndrome
 
Proteinuria sobh
Proteinuria sobhProteinuria sobh
Proteinuria sobh
 
NEPHROTIC SYNDROME by EKE E.P.
NEPHROTIC SYNDROME by EKE E.P.NEPHROTIC SYNDROME by EKE E.P.
NEPHROTIC SYNDROME by EKE E.P.
 
Proteinuira & Glomerular Disease, Dr. Sara Arnold, 11/8/14
Proteinuira & Glomerular Disease, Dr. Sara Arnold, 11/8/14Proteinuira & Glomerular Disease, Dr. Sara Arnold, 11/8/14
Proteinuira & Glomerular Disease, Dr. Sara Arnold, 11/8/14
 
Nephrotic syndrome in children. for under graduates
Nephrotic syndrome in children. for under graduatesNephrotic syndrome in children. for under graduates
Nephrotic syndrome in children. for under graduates
 
Nephrotic syndrome
Nephrotic syndromeNephrotic syndrome
Nephrotic syndrome
 
Nephrotic syndrome final
Nephrotic syndrome finalNephrotic syndrome final
Nephrotic syndrome final
 

Similar to Practical approach to_nephrotic_syndrome

.NET PATIENTS
.NET PATIENTS .NET PATIENTS
.NET PATIENTS PAIRS WEB
 
Acute interstitial nephritis
Acute interstitial nephritisAcute interstitial nephritis
Acute interstitial nephritisEmanElrefaie
 
CASE SENERIO Dr Ayman RefaieMD
 CASE SENERIO  Dr Ayman RefaieMD CASE SENERIO  Dr Ayman RefaieMD
CASE SENERIO Dr Ayman RefaieMDFAARRAG
 
NY Prostate Cancer Conference - D. Dearnaley - Session 4: Predicting clinical...
NY Prostate Cancer Conference - D. Dearnaley - Session 4: Predicting clinical...NY Prostate Cancer Conference - D. Dearnaley - Session 4: Predicting clinical...
NY Prostate Cancer Conference - D. Dearnaley - Session 4: Predicting clinical...European School of Oncology
 
Pulse vs. Daily Oral Cyclophosphamide for Induction of Remission in ANCA-Asso...
Pulse vs. Daily Oral Cyclophosphamide for Induction of Remission in ANCA-Asso...Pulse vs. Daily Oral Cyclophosphamide for Induction of Remission in ANCA-Asso...
Pulse vs. Daily Oral Cyclophosphamide for Induction of Remission in ANCA-Asso...Raj Kiran Medapalli
 
Mycophenolate Mofetil in Primary Glomerulonephritis
Mycophenolate Mofetil in Primary GlomerulonephritisMycophenolate Mofetil in Primary Glomerulonephritis
Mycophenolate Mofetil in Primary Glomerulonephritisedwinchowyw
 
8 Severe Acute Pancreatitis
8 Severe Acute Pancreatitis8 Severe Acute Pancreatitis
8 Severe Acute PancreatitisDang Thanh Tuan
 
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Pancreatic C...
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Pancreatic C...Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Pancreatic C...
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Pancreatic C...European School of Oncology
 
Pharmaceutical Care Oncology I
Pharmaceutical Care Oncology IPharmaceutical Care Oncology I
Pharmaceutical Care Oncology IGilang Rizki
 
m rcc optimal sequencing agents
m  rcc optimal sequencing agentsm  rcc optimal sequencing agents
m rcc optimal sequencing agentsmadurai
 
Hospital Medicine Pearls, VA ACP Meeting 2014
Hospital Medicine Pearls, VA ACP Meeting 2014Hospital Medicine Pearls, VA ACP Meeting 2014
Hospital Medicine Pearls, VA ACP Meeting 2014Jon Sweet
 
High grade glioma, standard of care & new advances..
High grade glioma, standard of care & new advances.. High grade glioma, standard of care & new advances..
High grade glioma, standard of care & new advances.. Osama Elzaafarany, MD.
 
nephrotic syndrome .pptx
nephrotic syndrome .pptxnephrotic syndrome .pptx
nephrotic syndrome .pptxMachoInglishMan
 
Tumor & GI Bleed: A case review by Dr Rajaie
Tumor & GI Bleed: A case review by Dr RajaieTumor & GI Bleed: A case review by Dr Rajaie
Tumor & GI Bleed: A case review by Dr Rajaiecosmosukm
 
Advanced & metastatic bladder cancer - Dr Alok Gupta
Advanced & metastatic bladder cancer - Dr Alok GuptaAdvanced & metastatic bladder cancer - Dr Alok Gupta
Advanced & metastatic bladder cancer - Dr Alok GuptaAlok Gupta
 

Similar to Practical approach to_nephrotic_syndrome (20)

.NET PATIENTS
.NET PATIENTS .NET PATIENTS
.NET PATIENTS
 
Acute interstitial nephritis
Acute interstitial nephritisAcute interstitial nephritis
Acute interstitial nephritis
 
CASE SENERIO Dr Ayman RefaieMD
 CASE SENERIO  Dr Ayman RefaieMD CASE SENERIO  Dr Ayman RefaieMD
CASE SENERIO Dr Ayman RefaieMD
 
NY Prostate Cancer Conference - D. Dearnaley - Session 4: Predicting clinical...
NY Prostate Cancer Conference - D. Dearnaley - Session 4: Predicting clinical...NY Prostate Cancer Conference - D. Dearnaley - Session 4: Predicting clinical...
NY Prostate Cancer Conference - D. Dearnaley - Session 4: Predicting clinical...
 
2 10[1]
2 10[1]2 10[1]
2 10[1]
 
Pulse vs. Daily Oral Cyclophosphamide for Induction of Remission in ANCA-Asso...
Pulse vs. Daily Oral Cyclophosphamide for Induction of Remission in ANCA-Asso...Pulse vs. Daily Oral Cyclophosphamide for Induction of Remission in ANCA-Asso...
Pulse vs. Daily Oral Cyclophosphamide for Induction of Remission in ANCA-Asso...
 
Mycophenolate Mofetil in Primary Glomerulonephritis
Mycophenolate Mofetil in Primary GlomerulonephritisMycophenolate Mofetil in Primary Glomerulonephritis
Mycophenolate Mofetil in Primary Glomerulonephritis
 
Gn master class
Gn master classGn master class
Gn master class
 
8 Severe Acute Pancreatitis
8 Severe Acute Pancreatitis8 Severe Acute Pancreatitis
8 Severe Acute Pancreatitis
 
3
33
3
 
9th non hodgkin's
9th non hodgkin's9th non hodgkin's
9th non hodgkin's
 
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Pancreatic C...
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Pancreatic C...Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Pancreatic C...
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Pancreatic C...
 
Molecular imaging and therapy in prostate cancer
Molecular imaging and therapy in prostate cancerMolecular imaging and therapy in prostate cancer
Molecular imaging and therapy in prostate cancer
 
Pharmaceutical Care Oncology I
Pharmaceutical Care Oncology IPharmaceutical Care Oncology I
Pharmaceutical Care Oncology I
 
m rcc optimal sequencing agents
m  rcc optimal sequencing agentsm  rcc optimal sequencing agents
m rcc optimal sequencing agents
 
Hospital Medicine Pearls, VA ACP Meeting 2014
Hospital Medicine Pearls, VA ACP Meeting 2014Hospital Medicine Pearls, VA ACP Meeting 2014
Hospital Medicine Pearls, VA ACP Meeting 2014
 
High grade glioma, standard of care & new advances..
High grade glioma, standard of care & new advances.. High grade glioma, standard of care & new advances..
High grade glioma, standard of care & new advances..
 
nephrotic syndrome .pptx
nephrotic syndrome .pptxnephrotic syndrome .pptx
nephrotic syndrome .pptx
 
Tumor & GI Bleed: A case review by Dr Rajaie
Tumor & GI Bleed: A case review by Dr RajaieTumor & GI Bleed: A case review by Dr Rajaie
Tumor & GI Bleed: A case review by Dr Rajaie
 
Advanced & metastatic bladder cancer - Dr Alok Gupta
Advanced & metastatic bladder cancer - Dr Alok GuptaAdvanced & metastatic bladder cancer - Dr Alok Gupta
Advanced & metastatic bladder cancer - Dr Alok Gupta
 

More from Loveis1able Khumpuangdee (20)

Rollup01
Rollup01Rollup01
Rollup01
 
Protec
ProtecProtec
Protec
 
Factsheet hfm
Factsheet hfmFactsheet hfm
Factsheet hfm
 
Factsheet
FactsheetFactsheet
Factsheet
 
Eidnotebook54
Eidnotebook54Eidnotebook54
Eidnotebook54
 
Data l3 148
Data l3 148Data l3 148
Data l3 148
 
Data l3 147
Data l3 147Data l3 147
Data l3 147
 
Data l3 127
Data l3 127Data l3 127
Data l3 127
 
Data l3 126
Data l3 126Data l3 126
Data l3 126
 
Data l3 113
Data l3 113Data l3 113
Data l3 113
 
Data l3 112
Data l3 112Data l3 112
Data l3 112
 
Data l3 92
Data l3 92Data l3 92
Data l3 92
 
Data l3 89
Data l3 89Data l3 89
Data l3 89
 
Data l2 80
Data l2 80Data l2 80
Data l2 80
 
Hfm reccomment10072555
Hfm reccomment10072555Hfm reccomment10072555
Hfm reccomment10072555
 
Hfm work2550
Hfm work2550Hfm work2550
Hfm work2550
 
Factsheet hfm
Factsheet hfmFactsheet hfm
Factsheet hfm
 
Publichealth
PublichealthPublichealth
Publichealth
 
แนวทางการดาเน ํ นงานป ิ องก ้ นควบค ั มการระบาดของโรคม ุ ือ เท้า ปาก สําหรบแพ...
แนวทางการดาเน ํ นงานป ิ องก ้ นควบค ั มการระบาดของโรคม ุ ือ เท้า ปาก สําหรบแพ...แนวทางการดาเน ํ นงานป ิ องก ้ นควบค ั มการระบาดของโรคม ุ ือ เท้า ปาก สําหรบแพ...
แนวทางการดาเน ํ นงานป ิ องก ้ นควบค ั มการระบาดของโรคม ุ ือ เท้า ปาก สําหรบแพ...
 
hand foot mouth
hand foot mouthhand foot mouth
hand foot mouth
 

Recently uploaded

Expanded definition: technical and operational
Expanded definition: technical and operationalExpanded definition: technical and operational
Expanded definition: technical and operationalssuser3e220a
 
Active Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfActive Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfPatidar M
 
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...Team Lead Succeed – Helping you and your team achieve high-performance teamwo...
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...Association for Project Management
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxHumphrey A Beña
 
Man or Manufactured_ Redefining Humanity Through Biopunk Narratives.pptx
Man or Manufactured_ Redefining Humanity Through Biopunk Narratives.pptxMan or Manufactured_ Redefining Humanity Through Biopunk Narratives.pptx
Man or Manufactured_ Redefining Humanity Through Biopunk Narratives.pptxDhatriParmar
 
Oppenheimer Film Discussion for Philosophy and Film
Oppenheimer Film Discussion for Philosophy and FilmOppenheimer Film Discussion for Philosophy and Film
Oppenheimer Film Discussion for Philosophy and FilmStan Meyer
 
Multi Domain Alias In the Odoo 17 ERP Module
Multi Domain Alias In the Odoo 17 ERP ModuleMulti Domain Alias In the Odoo 17 ERP Module
Multi Domain Alias In the Odoo 17 ERP ModuleCeline George
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptxmary850239
 
DIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptx
DIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptxDIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptx
DIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptxMichelleTuguinay1
 
Mental Health Awareness - a toolkit for supporting young minds
Mental Health Awareness - a toolkit for supporting young mindsMental Health Awareness - a toolkit for supporting young minds
Mental Health Awareness - a toolkit for supporting young mindsPooky Knightsmith
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfJemuel Francisco
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management SystemChristalin Nelson
 
ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfVanessa Camilleri
 
Narcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfNarcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfPrerana Jadhav
 
Measures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped dataMeasures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped dataBabyAnnMotar
 
Grade Three -ELLNA-REVIEWER-ENGLISH.pptx
Grade Three -ELLNA-REVIEWER-ENGLISH.pptxGrade Three -ELLNA-REVIEWER-ENGLISH.pptx
Grade Three -ELLNA-REVIEWER-ENGLISH.pptxkarenfajardo43
 
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...Nguyen Thanh Tu Collection
 
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...DhatriParmar
 
Mythology Quiz-4th April 2024, Quiz Club NITW
Mythology Quiz-4th April 2024, Quiz Club NITWMythology Quiz-4th April 2024, Quiz Club NITW
Mythology Quiz-4th April 2024, Quiz Club NITWQuiz Club NITW
 

Recently uploaded (20)

Expanded definition: technical and operational
Expanded definition: technical and operationalExpanded definition: technical and operational
Expanded definition: technical and operational
 
Active Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfActive Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdf
 
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...Team Lead Succeed – Helping you and your team achieve high-performance teamwo...
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
 
Man or Manufactured_ Redefining Humanity Through Biopunk Narratives.pptx
Man or Manufactured_ Redefining Humanity Through Biopunk Narratives.pptxMan or Manufactured_ Redefining Humanity Through Biopunk Narratives.pptx
Man or Manufactured_ Redefining Humanity Through Biopunk Narratives.pptx
 
Oppenheimer Film Discussion for Philosophy and Film
Oppenheimer Film Discussion for Philosophy and FilmOppenheimer Film Discussion for Philosophy and Film
Oppenheimer Film Discussion for Philosophy and Film
 
Multi Domain Alias In the Odoo 17 ERP Module
Multi Domain Alias In the Odoo 17 ERP ModuleMulti Domain Alias In the Odoo 17 ERP Module
Multi Domain Alias In the Odoo 17 ERP Module
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx
 
DIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptx
DIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptxDIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptx
DIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptx
 
Mental Health Awareness - a toolkit for supporting young minds
Mental Health Awareness - a toolkit for supporting young mindsMental Health Awareness - a toolkit for supporting young minds
Mental Health Awareness - a toolkit for supporting young minds
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
 
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptxINCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management System
 
ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdf
 
Narcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfNarcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdf
 
Measures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped dataMeasures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped data
 
Grade Three -ELLNA-REVIEWER-ENGLISH.pptx
Grade Three -ELLNA-REVIEWER-ENGLISH.pptxGrade Three -ELLNA-REVIEWER-ENGLISH.pptx
Grade Three -ELLNA-REVIEWER-ENGLISH.pptx
 
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...
31 ĐỀ THI THỬ VÀO LỚP 10 - TIẾNG ANH - FORM MỚI 2025 - 40 CÂU HỎI - BÙI VĂN V...
 
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
 
Mythology Quiz-4th April 2024, Quiz Club NITW
Mythology Quiz-4th April 2024, Quiz Club NITWMythology Quiz-4th April 2024, Quiz Club NITW
Mythology Quiz-4th April 2024, Quiz Club NITW
 

Practical approach to_nephrotic_syndrome

  • 1. PRACTICAL APPROACH TO PATIENTS WITH NEPHROTIC SYNDROME Vasant Sumethkul M.D. Professor of Medicine Ramathibodi Hospital Mahidol University
  • 2. ตวอยางผู วย ตัวอยางผปวย หญิงไทยโสดอายุ 40 ป มาโรงพยาบาลดวยอาการบวม และยุบ เปนและหาย มา 1 เดอน ป ื มีประวัติปสสาวะเปนฟอง แตไมมีเลือด และปริมาณปสสาวะออกดี ไม ี ป ไ มโรคประจํําตััว และปฏิเิ สธการทานยาเปนประจํํา ป ป ป
  • 3. T 36 BP 140/90 HR 80 Not pale, no jaundice, pitting edema 4+ Heart no gallop rhythm Lung no crepitation L i i Abdomen no palpable mass, fluid thrill Positive, no superficial vein dilatation
  • 4.
  • 5.
  • 6. CBC Hb 13.0 WBC 8500 PMN 70 L30 platelet 240,000 UA sp gr 1020, protein 4+, RBC 3-5 WBC 0-1, oval fat body 1-2, no cast 0 1, 1 2, spot UPCR = 4 TP 70 G/L, Albumin 20 G/L, Chol Ch l 350 mg/dl, Triglyceride 300 mg/dl /dl T i l id /dl BUN 10 mg/dl, Serum Cr 1.2 mg/dl
  • 7.
  • 8. What should you do next ? 1. Screen for ANA, anti DNA,C3, C4, CH 50 , , , , 2. Bed rest and furosemide 40 mg/day g y 3. 3 Start prednisolone 1 mg/kg/day 4. Collect 4 C ll t 24 h hour urine protein i t i
  • 9.
  • 10.
  • 11.
  • 12. other 3% 3% 3% 4% IgA IgM 19% Membranous 29% ain cgn 10% dn fsgs 6% lupus 4% 1% 18% mes gn minimal change Figure 3: Renal Histopathology of patients with nephrotic range proteinuria (N=217)
  • 13. Percent of Secondary Glomerulonephritis post inf 100% lupus 80% henoch-sc 60% MM 40% light_c 20% DN 0% Cryo Anti GBM <20 20-40 40-60 >60 Amyloidos Age group (yrs) Figure 2: Secondary glomerulonephritis by age (n=391)
  • 14. ผล ANA negative, anti DNA negative C3, C4 and CH 50 within normal limit HBsAg negative, anti HCV negative, g g , g , Anti HIV (with consent) negative CXR no pulmonary infiltration Stool examination ; no p parasite found ผูปวยยังมีอาการบวม และน้าหนักขึ้น 2 กิโลกรัม ใน 1 week ู ํ
  • 15. What should you do next ? 1. Bed rest and furosemide 40 mg/day g y 2. Start prednisolone 1 mg/kg/day 3. 3 Advise renal biopsy 4. Repeat serum creatinine 4 R t ti i
  • 16. Percent of Primary GN 100% mini 80% Membranous 60% fsgs mes gn 40% IgM 20% IgA mpgn 0% crescentic gn <20 20 40 20-40 40 60 40-60 >60 Age group (yrs) Figure 1: Primary glomerulonephritis by age (n=568)
  • 17.
  • 18. The patient deny renal biopsy and received prednisolone 50 mg/daily for 4 weeks. How can you characterize the response to corticosteroid ? 1. 1 Diuresis 2. Decrease body weight 3. Decrease proteinuria 3 D t i i 4. Increase serum albumin 5. Decrease serum cholesterol
  • 19. Clinical findings that strongly against the diagnosis of MCNS 1. RBC cast 2. Hypocomplementemia 3. Gross hematuria 4. 4 Severe uncontrolled hypertension 5. Rapidly progressive renal failure 6. 6 Organomegaly O l
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25. The patient received prednisolone 50 mg/daily for 8 weeks. Spot UPCR decrease to 1.5 p Serum albumin = 25 G/L. What should you do next ? 1. 1 Continue prednisolone 50 mg/daily to 16 weeks 2. 2 Add cyclophosphamide 100 mg/day l h h id /d 3. Add cyclosporin 150 mg/day 4. Advise renal biopsy
  • 26.
  • 27.
  • 28.
  • 29. The patient agree for renal biopsy at 8 weeks, the results are shown here. What is your diagnosis ?
  • 30.
  • 31.
  • 32.
  • 33. After renal biopsy, the patient receive prednisolone 30-40 mg/daily and cyclophosphamide 100 mg/day for y p p g y another 8 weeks. At 16 weeks, proteinuria is 2+ spot UPCR = 0 5 0.5 Serum albumin increase to 38 G/L What should you do next ?
  • 34. 1. Increase prednisolone to 40 mg/day and continue cyclophosphamide 100 mg/day for another 4 weeks 2. Add cyclosporin ; keep trough level 75-120 ng/dl 3. Continue low dose of Prednisolone and cyclophosphamide and add ACEI keep BP < 130/80 4. Repeat renal biopsy
  • 35.
  • 36. Response to therapy of MCNS 1. Complete remission: Proteinuria trace or negative X 2 24 hour Proteinuria < 300 mg/day i i / 2. 2 Partial remission: Proteinuria < 1-2 gram/day g y Proteinuria < 50 % of baseline with normal serum albumin
  • 37. Steroid non responsive (resistance) MCNS 1. Proteinuria > 3 5 gram /d after 16 weeks 1 P t i i 3.5 /day ft k 2. 2 Patients who do not have criteria for partial remission after adequate therapy q py
  • 38. If renal biopsy shows FSGS : What is the different approach ?
  • 39.
  • 40.
  • 41.
  • 42.
  • 43.
  • 44.
  • 45.
  • 46.
  • 47.
  • 48. If renal biopsy shows Membranous glomerulonephritis : What is the different approach ?
  • 49.
  • 50.
  • 51.
  • 52.
  • 53.
  • 54.
  • 55.
  • 56.
  • 57. SUMMARY 1. The prediction of renal pathology from clinical setting is not accurate 2. The long term prognosis of p g p g patient with nephrotic syndrome is generally good 3. Over immunosuppression should be avoided
  • 58. Thank you for your attention